8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers

An open-label research study, published in Supportive Care in Cancer, found that 8 hours of bedrest in the supine position, rather than the standard 6 hours, after intrathecal chemotherapy decreases the risk of adverse events, including post-lumbar puncture headache, back pain, nausea/vomiting, and brain herniation.

Oncology Nurse Advisor